Atlas Trials

Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.

Clinical trial NCT06613399 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06613399
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2025-01-01
Primary completion
2026-01-01
Enrollment
324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.